Roche receives USFDA approval for Ocrevus Zunovo for treatment of progressive multiple sclerosis
This approval is backed by a decade of proven safety and efficacy data of Ocrevus® IV, with over 350,000 people treated globally
This approval is backed by a decade of proven safety and efficacy data of Ocrevus® IV, with over 350,000 people treated globally
The brand will establish an integrated hearing care ecosystem at Neuberg Diagnostics centers across the length and breadth of the country
The fresh funds will be used to enhance customer relationships, expand operations and develop state-of-the-art service
For the 2024 outlook, sales growth is now expected to be 22-28% at CER
Globally, colorectal cancer impacts 1.9 million people each year, standing as a leading cause of cancer mortality
India boasts the largest livestock population, with 536 million livestock and 851 million poultry
Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history
Cresset’s new India site will support the growing demands of Cresset’s APAC customer base
The company has posted net profit) of Rs.18.88 crores for the Financial Year ended March 31, 2024
The drug will be manufactured at the group's topical manufacturing facility at Changodar, Ahmedabad (India)
Subscribe To Our Newsletter & Stay Updated